A scalable chitosan-based nanocarrier platform loaded with essential oils that safely triggers enhanced biosynthesis of resveratrol and sugars in grapevines independent of climate or pathogen stress. Validated on Arabidopsis, with field testing planned in pilot vineyards to improve grape quality, disease resistance, and wine value.
This solution offers a novel agricultural biotechnology that enables vineyard managers and wine producers to safely and consistently enhance the resveratrol and sugar content of grapes on demand. The approach uses biodegradable chitosan nanocarriers loaded with essential oils to deliver hormesis-inducing molecules directly to grapevines. By triggering the plant's natural defense and secondary metabolism pathways, the technology increases production of valuable polyphenols and sugars without requiring specific microclimatic stress conditions or pathogen outbreaks. The result is improved grape quality, enhanced disease resistance, and greater consistency in vintage outcomes.
Key features:
The biological rationale is grounded in the observation that resveratrol and sugars accumulate in grapes as natural defense compounds under stress. By delivering essential oils via chitosan nanocarriers, the technology replicates this defense signaling safely and predictably, bypassing the need for environmental triggers.
The technology has been validated at the laboratory scale using the Arabidopsis thaliana model system, demonstrating enhanced disease resistance to Botrytis cinerea with statistical significance (p<0.01). Scalable prototypes of the chitosan nanocarriers have been formulated, and dose-response curves have been established. Future validation steps include determining cargo release rates and nanocarrier stability, conducting field testing in a pilot-scale vineyard with HPLC-based resveratrol quantification, and evaluating disease resistance markers in grapevines. The team is seeking industry partners to demonstrate feasibility and advance toward commercial vineyard deployment.
The University of Illinois Urbana‑Champaign is a flagship public research university with large‑scale research capacity and a broad academic portfolio. An on‑campus Research Park co‑locates corporate R&D teams and startups with faculty, while the National Center for Supercomputing Applications provides advanced computing and data capabilities for collaboration. Integration with a regional health system and an engineering‑based college of medicine enables clinical translation, and a long‑standing extension network links campus innovation to partners statewide. Research is supported by competitive federal funding from NSF, NIH, DOE, USDA, and DoD. A technology transfer office streamlines IP, licensing, and startups, complemented by incubators and prototyping in the Research Park.